HomeAI · summaries
Storia in 5 fonti
Novo Nordisk stock trades at 4-year-low on the back of disappointing Alzheimer’s trial | Fortune
The stock of the Wegovy and Ozempic maker is down nearly 50% year to date.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Novo Nordisk shares plunge 10% after Alzheimer's drug trial fails to hit key target
Shares of Novo Nordisk plunged after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer's disease failed to meet its main goal.
- ·
cincodias.elpais.com
Novo Nordisk se desploma en Bolsa ante los malos resultados de los ensayos de uno de sus fármacos contra el Alzhéimer
La acción llega a caer un 12% hasta sus precios mínimos en más de cuatro años
